346
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?

, , , , &
Pages 143-150 | Received 24 May 2015, Accepted 29 Nov 2015, Published online: 15 Jan 2016

References

  • Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med 2009;37:2552–8.
  • Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Beginning and ending supportive therapy for the kidney (BEST Kidney) investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813–18.
  • Wen Y, Jiang L, Xu Y, Qian CY, Li SS, Qin TH, Chen EZ, Lin JD, Ai YH, Wu DW, Wang YS, Sun RH, Hu ZJ, Cao XY, Zhou FC, He ZY, Zhou LH, An YZ, Kang Y, Ma XC, Yu XY, Zhao MY, Xi XM, Du B, China Critical Care Clinical Trial Group (CCCCTG). Prevalence, risk factors, clinical course, and outcome of acute kidney injury in Chinese intensive care units: a prospective cohort study. Chin Med J 2013;126:4409–16.
  • Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006;10:R73.
  • Nejat M, Pickering JW, Endre ZH. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant 2010;25:3283–9.
  • Herget-Rosenthal S, Marggraf G, Hüsing J, Göring F, Pietruck F, Janssen O, Philipp T, Kribben A. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:1115–22.
  • Aydoğdu M, Gürsel G, Sancak B, Yeni S, Sarı G, Taşyürek S, Türk M, Yüksel S, Senes M, Ozis TN. The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and cystatin C in early diagnosis of septic acute kidney injury in critically ill patients. Dis Markers 2013;34:237–46.
  • Bagshaw SM, Gibney RT. Conventional markers of kidney function. Crit Care Med 2008;36:S152–8.
  • Kwon S, Hyun J, Jeon J, Noh H, Han D. Subtle change of cystatin C, with or without acute kidney injury, associated with increased mortality in the intensive care unit. J Crit Care 2011;26:566–71.
  • Fouad M, Boraie M. Cystatin C as an early marker of acute kidney injury and predictor of mortality in the intensive care unit after acute myocardial infarction. Arab J Nephrol Transplant 2013;6:21–6.
  • Sagheb MM, Namazi S, Geramizadeh B, Karimzadeh A, Oghazian MB, Karimzadeh I. Serum cystatin C as a marker of renal function in critically ill patients with normal serum creatinine. Nephrourol Mon 2014;6:e15224.
  • Carlier M, Dumoulin A, Janssen A, Picavet S, Vanthuyne S, Eynde RV, Vanholder R, Delanghe J, De Shoenmakere G, De Waele JJ, Hoste EAJ. Comparison of different equations to assess glomerular filtration in critically ill patients. Intensive Care Med 2015;41:427–35.
  • National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39:S1–266.
  • Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute dialysis quality initiative work group: Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R205–12.
  • Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–6.
  • Dade-Behring. Dade Behring Marburg GmbH Germany N Latex Cystatin C. Packet Insert. Code no. OQNM G13 E0541 (109) CS/R. Edition September 2004.
  • Delanghe JR, Speeckaert MM. Creatinine determination according to Jaffe – what does it stand for? NDT Plus 2011;4:83–6.
  • Portal AJ, Mcphail MJ, Bruce M, Coltart I, Slack A, Sherwood R, Heaton ND, Shawcross D, Wendon JA, Heneghan MA. Neutrophil gelatinase-associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver Transpl 2010;16:1257–66.
  • Chung MY, Jun DW, Sung SA. Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. Korean J Hepatol 2010;16:301–7.
  • Bongiovanni C, Magrini L, Salerno G, Gori CS, Cardelli P, Hur M, Buggi M, Di Somma S. Serum cystatin C for the diagnosis of acute kidney injury in patients admitted in the emergency department. Dis Markers 2015;2015:416059.
  • Le Bricon T, Leblanc I, Benlakehal M, Gay-Bellile C, Erlich D, Boudaud S. Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates. Clin Chem Lab Med 2005;43:953–7.
  • Dalboni MA, Beraldo Dde O, Quinto BM, Blaya R, Narciso R, Oliveira M, Monte JC, Durão Mde S, Cendoroglo M, Pavão OF, Batista MC. Cystatin C at admission in the intensive care unit predicts mortality among elderly patients. ISRN Nephrol 2013;24:673–95.
  • Perianayagam MC, Seabra VF, Tighiouart H, Liangos O, Jaber BL. Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study. Am J Kidney Dis 2009;54:1025–33.
  • Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, Lupi I, Pellegrini G, Bartalena L, Bogazzi F, Martino E. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 2005;28:346–9.
  • Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009;75:652–60.
  • Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis 2013;62:595–603.
  • Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 2005;16:1404–12.
  • Lima RM, Navarro LH, Nakamura G, Solanki DR, Castiglia YM, Vianna PT, Ganem EM. Serum cystatin C is a sensitive early marker for changes in the glomerular filtration rate in patients undergoing laparoscopic surgery. Clinics (Sao Paulo) 2014;69:378–83.
  • Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, Vera M, Piera C, Darnell A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000;36:29–34.
  • Prigent A. Monitoring renal function and limitations of renal function tests. Rev Semin Nucl Med 2008;38:32–46.
  • Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini E, Miccoli R, Del Prato S, Penno G. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem 2007;53:480–8.
  • Mussap M, Dalla Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002;61:1453–61.
  • Brondén B, Eyjolfsson A, Blomquist S, Dardashti A, Ederoth P, Bjursten H. Evaluation of cystatin C with iohexol clearance in cardiac surgery. Acta Anaesthesiol Scand 2011;55:196–202.
  • Wang QP, Gu JW, Zhan XH, Li H, Luo XH. Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting. Ann Clin Biochem 2009;46:495–500.
  • James MT, Hemmelgarn BR, Wiebe N, Pannu N, Manns BJ, Klarenbach SW, Tonelli M, Alberta Kidney Disease Network. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 2010;376:2096–103.
  • Gonzalez F, Vincent F. Biomarkers for acute kidney injury in critically ill patients. Minerva Anestesiol 2012;78:1394–403.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.